| SciPort RLP

2013 - 2023

Glivec STI571(IMATINIB MESYLATE)

PD Dr. ThomasKindler

2013 - 2015

PI3K/AKT/mTOR pathway in B cells-‐a novel link between lymphoid tissue architecture, inflammation and lymphoma development

Dr. NadineHövelmeyer

2013 - 2016

Analysen zur Wirkung von Typ-I-Interferonen auf Tumor-assoziierte Toleranzprozesse (Deutsche Krebshilfe)

Univ.-Prof. Dr. KerstinSteinbrink

2013 - 2015

Bimatoprost

Dr. Dr. KatrinLorenz

2013 - 2016

Analysis of interaction between innate and adaptive immunity in contact allergen-specific inflammation (DFG-Einzelantrag STE 791/6-1)

Univ.-Prof. Dr. KerstinSteinbrink

2013 - 2016

REPARO NGF 0212: An 8-week phase I/II, multicenter, randomized, double-masked, vehicle controlled parallel group study with a 48 or 56 week open-label follow-up period to evaluate the safety and efficacy of two doses (10µg/ml and 20µg/ml) of recombinant human nerve growth factor eye drops solution versus vehicle in patients with Stage 2 and 3 of neurotrophic keratitis.

Dr. Dr. KatrinLorenz

2013 - 2016

Initial Training Network for Neurological disorders orchestrated by cytoKines

Univ.-Prof. Ph.D. AriWaisman

2013 - 2015

BRENDA (#452)

Univ.-Prof. Dr. GeorgHeß

2013 - 2014

Die Rolle der Proteinkinase AKT in der B-Zell Lymphomgenese

Dr. NadineHövelmeyer

2013 - 2015

Detection of pulmonary hemodynamics in probands and patients with pulmonary hypertension using high-resolution phase contrast MRI (MAIFOR)

Dr. GesineWirth

Starten Sie Ihre Suche...

Johannes Gutenberg-Universität Mainz